Abstract
In our continuous efforts to identify and develop novel targeted cancer treatments, a new morpholino-thiazole scaffold active against PI3Kβ has been identified. This Letter reports the optimization of this compound class to develop PI3Kβ isoform-selective inhibitors with suitable pharmacological properties.
Keywords:
PI3Kβ; PTEN; Thiazole; pAKT.
Copyright © 2014 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amides / chemical synthesis
-
Amides / chemistry*
-
Animals
-
Binding Sites
-
Caco-2 Cells
-
Carboxylic Acids / chemical synthesis
-
Carboxylic Acids / chemistry*
-
Carboxylic Acids / pharmacology
-
Humans
-
Indoles / chemistry*
-
Male
-
Molecular Docking Simulation
-
Permeability / drug effects
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphoinositide-3 Kinase Inhibitors*
-
Protein Isoforms / antagonists & inhibitors
-
Protein Isoforms / metabolism
-
Protein Kinase Inhibitors / chemical synthesis
-
Protein Kinase Inhibitors / chemistry*
-
Protein Kinase Inhibitors / pharmacology
-
Protein Structure, Tertiary
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / metabolism
-
Rats
-
Rats, Sprague-Dawley
-
Thiazoles / chemistry
Substances
-
Amides
-
Carboxylic Acids
-
Indoles
-
Phosphoinositide-3 Kinase Inhibitors
-
Protein Isoforms
-
Protein Kinase Inhibitors
-
Thiazoles
-
indoline
-
Proto-Oncogene Proteins c-akt